CIK: 0001425738 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value ($000): $1,027,816 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SRRK | SCHOLAR ROCK HLDG CORP | 3,904,456 | $145,402 | 14.1% | $12.18 | +187.1% | COM | 80706P103 |
| KRYS | KRYSTAL BIOTECH INC | 661,388 | $116,755 | 11.4% | $58.73 | +154.9% | COM | 501147102 |
| STOK | STOKE THERAPEUTICS INC | 4,175,542 | $98,125 | 9.5% | $9.00 | +90.4% | COM | 86150R107 |
| ZYME | ZYMEWORKS INC | 3,705,750 | $63,294 | 6.2% | $7.05 | +103.1% | COM | 98985Y108 |
| ADCT | ADC THERAPEUTICS SA | 15,666,731 | $62,667 | 6.1% | $19.52 | -83.9% | SHS | H0036K147 |
| IMNM | IMMUNOME INC | 5,023,385 | $58,824 | 5.7% | $10.65 | -6.6% | COM | 45257U108 |
| LIVN | LIVANOVA PLC | 926,799 | $48,546 | 4.7% | $70.40 | -28.5% | SHS | G5509L101 |
| RGNX | REGENXBIO INC | 4,693,389 | $45,291 | 4.4% | $22.74 | -61.1% | COM | 75901B107 |
| — | AKERO THERAPEUTICS INC | 747,818 | $35,506 | 3.5% | $33.38 | — | COM | 00973Y108 |
| NRIX | NURIX THERAPEUTICS INC | 3,678,394 | $33,988 | 3.3% | $20.56 | -49.5% | COM | 67080M103 |
| BEAM | BEAM THERAPEUTICS INC | 1,387,559 | $33,676 | 3.3% | $26.47 | -24.8% | COM | 07373V105 |
| COGT | COGENT BIOSCIENCES INC | 2,209,118 | $31,723 | 3.1% | $9.95 | +19.0% | COM | 19240Q201 |
| ABSI | ABSCI CORPORATION | 8,253,316 | $25,090 | 2.4% | $19.01 | -85.5% | COM | 00091E109 |
| NGNE | NEUROGENE INC | 1,299,022 | $22,512 | 2.2% | $21.64 | -7.2% | COM | 64135M105 |
| — | 89BIO INC | 1,473,136 | $21,655 | 2.1% | $11.28 | — | COM | 282559103 |
| IDYA | IDEAYA BIOSCIENCES INC | 742,017 | $20,190 | 2.0% | $27.49 | -12.0% | COM | 45166A102 |
| ANNX | ANNEXON INC | 6,300,644 | $19,217 | 1.9% | $13.35 | -81.4% | COM | 03589W102 |
| FATE | FATE THERAPEUTICS INC | 12,872,946 | $16,220 | 1.6% | $13.12 | -91.8% | COM | 31189P102 |
| RAPT | RAPT THERAPEUTICS INC | 552,594 | $14,251 | 1.4% | $7.63 | +71.5% | COM NEW | 75382E208 |
| STTK | SHATTUCK LABS INC | 5,539,724 | $13,240 | 1.3% | $32.14 | -96.2% | COM | 82024L103 |
| SLDB | SOLID BIOSCIENCES INC | 1,899,342 | $11,719 | 1.1% | $4.65 | +25.7% | COM NEW | 83422E204 |
| SLN | SILENCE THERAPEUTICS PLC | 2,164,777 | $11,235 | 1.1% | $18.53 | — | ADS | 82686Q101 |
| NUVB | NUVATION BIO INC | 3,031,009 | $11,215 | 1.1% | $11.18 | -75.6% | COM CL A | 67080N101 |
| KROS | KEROS THERAPEUTICS INC | 552,506 | $8,741 | 0.9% | $59.30 | -75.1% | COM | 492327101 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 327,008 | $8,460 | 0.8% | $11.60 | +99.8% | COM NEW | 15117B202 |
| ATRA | ATARA BIOTHERAPEUTICS INC | 441,701 | $6,330 | 0.6% | $15.04 | -23.5% | COM NEW | 046513206 |
| FOLD | AMICUS THERAPEUTICS INC | 777,178 | $6,124 | 0.6% | $10.35 | -31.2% | COM | 03152W109 |
| ALXO | ALX ONCOLOGY HLDGS INC | 3,332,983 | $6,099 | 0.6% | $15.46 | -94.4% | COM | 00166B105 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 129,364 | $5,303 | 0.5% | $44.21 | -7.6% | COM | G31249108 |
| CBLL | CERIBELL INC | 435,239 | $5,001 | 0.5% | $27.25 | -50.5% | COM | 15678C102 |
| XERS | XERIS BIOPHARMA HOLDINGS INC | 451,099 | $3,672 | 0.4% | $2.16 | +207.6% | COM | 98422E103 |
| VTYX | VENTYX BIOSCIENCES INC | 1,073,386 | $3,338 | 0.3% | $2.09 | +26.9% | COM | 92332V107 |
| — | LAVA THERAPEUTICS NV | 2,074,372 | $3,236 | 0.3% | $15.19 | — | SHS | N51517105 |
| — | REPARE THERAPEUTICS INC | 1,586,174 | $2,792 | 0.3% | $30.51 | — | COM | 760273102 |
| IVVD | INVIVYD INC | 2,285,320 | $2,514 | 0.2% | $18.61 | -95.2% | COM | 00534A102 |
| PLRX | PLIANT THERAPEUTICS INC | 1,591,695 | $2,356 | 0.2% | $22.82 | -93.3% | COM | 729139105 |
| REPL | REPLIMUNE GROUP INC | 535,818 | $2,245 | 0.2% | $16.51 | -61.3% | COM | 76029N106 |
| PRME | PRIME MEDICINE INC | 87,118 | $483 | 0.0% | $14.27 | -71.5% | COM | 74168J101 |
| KLRS | KALARIS THERAPEUTICS INC | 82,955 | $479 | 0.0% | $9.79 | -66.2% | COM | 482929106 |
| BOLD | BOUNDLESS BIO INC | 245,458 | $302 | 0.0% | $14.25 | -91.9% | COM | 10170A100 |